The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Incidence, Prevalence, and Clinical Significance of Abnormal Hematologic Indices in Compensated Cirrhosis
Open accessAbstract
Background & Aims Patients with cirrhosis develop abnormal hematologic indices (HI) from multiple factors, including hypersplenism. We aimed to analyze the sequence of events and determine whether abnormal HI has prognostic significance. Methods We analyzed a database of 213 subjects with compensated cirrhosis without esophageal varices. Subjects were followed for approximately 9 years until the development of varices or variceal bleeding or completion of the study; 84 subjects developed varices. Abnormal HI was defined as anemia at baseline (hemoglobin, ≤13.5 g/dL for men and 11.5 g/dL for women), leukopenia (white blood cell counts, ≤4000/mm3), or thrombocytopenia (platelet counts, ≤150,000/mm3). The primary end points were death or transplant surgery. Results Most subjects had thrombocytopenia at baseline. Kaplan–Meier analysis showed that leukopenia occurred by 30 months (95% confidence interval, 18.5–53.6), and anemia occurred by 39.6 months (95% confidence interval, 24.1–49.9). Baseline thrombocytopenia (P = .0191) and leukopenia (P = .0383) were predictors of death or transplant, after adjusting for baseline hepatic venous pressure gradient (HVPG), and Child–Pugh scores. After a median of 5 years, a significant difference in death or transplant, mortality, and clinical decompensation was observed in patients who had leukopenia combined with thrombocytopenia at baseline compared with patients with normal HI (P < .0001). HVPG correlated with hemoglobin and white blood cell count (hemoglobin, r = −0.35, P < .0001; white blood cell count, r = −0.31, P < .0001). Conclusions Thrombocytopenia is the most common and first abnormal HI to occur in patients with cirrhosis, followed by leukopenia and anemia. A combination of leukopenia and thrombocytopenia at baseline predicted increased morbidity and mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
D'Amico, G., Garcia-Tsao, G., & Pagliaro, L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.013 · Cited by 2,687
Self-citationRipoll, C., Groszmann, R., Garcia–Tsao, G., Grace, N., Burroughs, A., Planas, R., Escorsell, A., Garcia–Pagan, J. C., Makuch, R., Patch, D., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.024 · Cited by 1,183
Self-citationBeta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis
Groszmann, R. J., Garcia-Tsao, G., Bosch, J., Grace, N. D., Burroughs, A. K., Planas, R., Escorsell, A., Garcia-Pagan, J. C., Patch, D., Matloff, D. S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044456 · Cited by 1,005
Self-citationSurvival and prognostic indicators in compensated and decompensated cirrhosis
D'amico, G., Morabito, A., Pagliaro, L., Marubini, E., & The Liver Study Group of ?V. Cervello? Hospital (1986) · Digestive Diseases and Sciences · doi:10.1007/bf01320309 · Cited by 575
A prospective study of bacterial infections in patients with cirrhosis
Caly, W. R., & Strauss, E. (1993) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80280-6 · Cited by 503
(1998) · PubMed · Cited by 440
Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study
Borzio, M., Salerno, F., Piantoni, L., Cazzaniga, M., Angeli, P., Bissoli, F., Boccia, S., Colloredo-Mels, G., Corigliano, P., Fornaciari, G., et al. (2001) · Digestive and Liver Disease · doi:10.1016/s1590-8658(01)80134-1 · Cited by 438
Realdi, G., The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP), Fattovich, G., Hadziyannis, S., Schalm, S. W., Almasio, P., Sanchez-Tapias, J., Christensen, E., Giustina, G., & Noventa, F. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80115-0 · Cited by 301
Bashour, F. N., Teran, C. J., & Mullen, K. D. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01117-5 · Cited by 252
Ripoll, C., Bañares, R., Rincón, D., Catalina, M.-V., Lo Iacono, O., Salcedo, M., Clemente, G., Núñez, O., Matilla, A., & Molinero, L.-M. (2005) · Hepatology · doi:10.1002/hep.20871 · Cited by 246
Self-citation
Cited by
Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia
Afdhal, N. H., Giannini, E. G., Tayyab, G., Mohsin, A., Lee, J.-W., Andriulli, A., Jeffers, L., McHutchison, J., Chen, P.-J., Han, K.-H., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110709 · Cited by 321
Robic, M. A., Procopet, B., Métivier, S., Péron, J. M., Selves, J., Vinel, J. P., & Bureau, C. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.01.051 · Cited by 310
Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
Sangro, B., Chan, S. L., Meyer, T., Reig, M., El-Khoueiry, A., & Galle, P. R. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.021 · Cited by 293
Liver Fibrosis Leading to Cirrhosis: Basic Mechanisms and Clinical Perspectives
Somnay, K., Wadgaonkar, P., Sridhar, N., Roshni, P., Rao, N., & Wadgaonkar, R. (2024) · Biomedicines · doi:10.3390/biomedicines12102229 · Cited by 70
Mechanisms and management of thrombosis in cancer: Focus on gastrointestinal malignancies
Monegatti, S., Martinelli, N., Friso, S., Spronk, H. M. H., & Cate, H. T. (2025) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.124.002203 · Cited by 10
Metadata
- Authors
- Qamar, A. A., Grace, N. D., Groszmann, R. J., Garcia–Tsao, G., Bosch, J., Burroughs, A. K., Ripoll, C., Maurer, R., Planas, R., Escorsell, A., Garcia–Pagan, J. C., Patch, D., Matloff, D. S., Makuch, R., & Rendon, G.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 7
- Issue
- 6
- Pages
- 689-695
- ISSN
- 1542-3565 (ISSN-L)
- OpenAlex
- W2105203257
- Cited by
- 275
- References
- 17
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Incidence, Prevalence, and Clinical Significance of Abnormal Hematologic Indices in Compensated Cirrhosis. https://app.cochat.ai/papers/10.1016/j.cgh.2009.02.021
- The paper
- Qamar, A. A., Grace, N. D., Groszmann, R. J., Garcia–Tsao, G., Bosch, J., Burroughs, A. K., Ripoll, C., Maurer, R., Planas, R., Escorsell, A., Garcia–Pagan, J. C., Patch, D., Matloff, D. S., Makuch, R., & Rendon, G. (2009). Incidence, Prevalence, and Clinical Significance of Abnormal Hematologic Indices in Compensated Cirrhosis. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2009.02.021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.